Objective. Students identify the mechanism of action, indications, nursing considerations, and adverse effects of medications commonly used in obstetric care including oxytocin, magnesium sulfate, terbutaline, and opioid and epidural analgesics.
This lesson, its worked examples and its practice questions has not yet been verified by a licensed clinician in the field or by a certification or approval body. It is a study draft and may contain errors. Do not use it to make decisions about any patient or medication. Always follow your instructor, your supervising professional, and current official references and regulations.
VoTechWorks program approval and accreditation are still in progress. Credentials are issued only by the certifying bodies named in each program, after their own exams.
Medications used in obstetric care act on the uterus, the central nervous system, and the cardiovascular system. Because changes in maternal condition affect the fetus directly, the LPN must recognize normal responses, early signs of toxicity, and the boundaries of independent practice versus actions that require immediate notification of the RN or provider.
Oxytocin is a synthetic form of the naturally occurring posterior-pituitary hormone that stimulates uterine contractions. It is used to induce or augment labor and to prevent or treat postpartum hemorrhage by promoting sustained uterine contraction after delivery.
Nursing considerations: Oxytocin is always given by intravenous infusion during labor, typically titrated in milliunits per minute (mU/min) by the RN following a facility protocol. The LPN role includes monitoring maternal vital signs, fetal heart rate (FHR) patterns on the electronic fetal monitor, and uterine contraction frequency, duration, and resting tone. Contractions lasting longer than 90 seconds or occurring more than five times in ten minutes (uterine tachysystole) are a safety concern requiring immediate escalation. Hypotension, water intoxication (from oxytocin's antidiuretic effect), and fetal heart rate decelerations are additional adverse effects to report.
Magnesium sulfate is used in obstetrics for two major indications: seizure prevention and treatment in preeclampsia/eclampsia, and short-term fetal neuroprotection in anticipated preterm birth before a specified gestational age per provider order. It acts as a central nervous system depressant by competing with calcium at neuromuscular junctions.
Signs of toxicity (in order of severity): loss of deep tendon reflexes (DTRs) — specifically the patellar reflex — is the first reliable sign. Respiratory depression follows, and cardiac arrest can occur at very high serum levels. Before and during infusion, the LPN monitors DTRs, respiratory rate, urinary output (magnesium is renally cleared; output below 25–30 mL/hr is a warning sign), and level of consciousness.
Antidote: Calcium gluconate is the antidote for magnesium toxicity and must be kept at the bedside during any magnesium infusion. Respiratory rate below 12 breaths per minute or absent DTRs requires stopping the infusion and notifying the RN immediately. Administration of the antidote and decisions about stopping a magnesium infusion are within the RN and provider scope; the LPN's priority is assessment, recognition, and immediate escalation.
Terbutaline is a beta-2 adrenergic agonist used as a tocolytic to temporarily slow or stop uterine contractions in preterm labor or to treat acute uterine tachysystole. Maternal side effects include tachycardia, palpitations, tremor, and hyperglycemia. It is contraindicated when continuation of pregnancy is unsafe. Monitor maternal pulse and blood pressure before and after administration.
Methylergonovine is an ergot alkaloid used exclusively postpartum to treat or prevent uterine atony and hemorrhage. It causes sustained uterine contraction. It is contraindicated in hypertension because it causes vasoconstriction and can markedly raise blood pressure. Always check maternal blood pressure before administration and withhold if the systolic is elevated per facility parameters or provider order. It is given intramuscularly in the postpartum period.
Opioids such as IV or IM morphine or fentanyl provide systemic analgesia during labor. They cross the placenta and can cause neonatal respiratory depression if given too close to delivery. Nursing considerations include monitoring maternal respiratory rate, oxygen saturation, sedation level, and FHR for late decelerations. Naloxone (Narcan) is the opioid antidote for the mother; a neonatal dose formulation may be used for the newborn per provider order if respiratory depression occurs at birth.
Epidural analgesia is the most common form of pain management in labor. A local anesthetic (e.g., bupivacaine) alone or combined with an opioid is infused into the epidural space by an anesthesia provider. LPN responsibilities include monitoring blood pressure (hypotension is the most common side effect), FHR, maternal temperature, bladder distension (the patient cannot feel urge to void), level of sensation, and motor function. The LPN does not initiate, manage, or troubleshoot the epidural catheter; those are RN and anesthesia provider responsibilities.
In most states, the LPN in obstetric settings works under the supervision of an RN. The LPN performs assessments, administers medications as directed, documents findings, and communicates changes promptly. Independent LPN actions include accurate assessment and timely escalation — not independent clinical decision-making about high-risk infusions. When in doubt, report and document.
Answer each question, then check it. Nothing is recorded; this is your own practice.
A free tech program — complimentary, as our commitment to get America working. Help us build VoTechWorks. Tell us what works, what doesn’t, and what you want to learn.